1. P174 Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. (26th April 2021) Authors: Coates, Laura C; Garrood, Toby; Gullick, Nicola; Helliwell, Philip; Kent, Toby; Marks, Jonathan; Tillett, William; Kaur-Papadakis, Daljit; Tahir, Hasan; Haaren, Stijn van; McInnes, Iain Journal: Rheumatology Issue: Volume 60(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. (7th July 2022) Authors: Coates, Laura C; Garrood, Toby; Gullick, Nicola; Helliwell, Philip; Kent, Toby; Marks, Jonathan; Tillett, William; Kaur-Papadakis, Daljit; Tahir, Hasan; van Haaren, Stijn; McInnes, Iain Journal: Rheumatology Issue: Volume 62:Number 1(2023) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗